MorieAGertzMDMACP

PubMed

• 70 citations
  Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.
  David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine
  American Journal of Transplantation. 2021-02-01
• 48 citations
  Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
  David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine
  American Journal of Transplantation. 2021-02-01
• 450 citations
  Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System
  Martha Grogan, Christopher G. Scott, Robert A. Kyle, Steven R. Zeldenrust, Morie A. Gertz
  Journal of the American College of Cardiology. 2016-09-06

Journal Articles

• Systemic Amyloidosis Recognition, Prognosis, and Therapy  
  Morie A Gertz, Angela Dispenzieri, JAMA
• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
  Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Morie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
• Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis  
  William J Litchy, Peter D Gorevic, Morie A Gertz, Amil M Shah, John L Berk, Peter J Dyck, The New England Journal of Medicine
• Potential new risks of lenalidomide  
  Gertz MA , Buadi FK, Leuk Lymphoma, 9/1/2014
• Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus  
  Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, Garcia-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, ..., Blood, 8/28/2014
• Risk adapted therapy for multiple myeloma: back to basics  
  Kumar SK, Gertz MA, Leuk Lymphoma, 4/22/2014
• Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma  
  Kourelis TV, Kumar SK, Srivastava G, Gertz MA , Lacy MQ, Buadi FK, Kyle RA, Dispenzieri A, Leukemia, 2/1/2014
• Immunoglobulin light chain amyloidosis  
  Merlini G, Comenzo RL, Seldin DC, Wechalekar A, Gertz MA, Expert Rev Hematol, 2/1/2014
• Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patients  
  Thyagarajan B, Arora M, Guan W, Barcelo H, Jackson S, Kumar S, Gertz M, Leuk Res, 11/1/2013
• Waldenstrom macroglobulinaemia: the key questions  
  D'Souza A, Ansell S, Reeder C, Gertz MA, Br J Haematol, 8/1/2013
• Second auto-SCT for treatment of relapsed multiple myeloma  
  Gonsalves WI, Gertz MA , Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Hogan WJ, Kumar SK, Bone Marrow Transplant, 4/1/2013
• IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia  
  Hodge LS, Ziesmer SC, Yang ZZ, Secreto FJ, Gertz MA , Novak AJ, Ansell SM, Blood, 11/1/2012
• Quantification of clonal circulating plasma cells in relapsed multiple myeloma  
  Gonsalves WI, Morice WG, Rajkumar V, Gupta V, Timm MM, Dispenzieri A, Buadi FK, Lacy MQ, Singh PP, Kapoor P, Gertz MA , Kumar SK, Br J Haematol, 8/12/2012
• Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies  
  Sinha S, Gertz MA , Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Micallef IN, Hogan WJ, Gastineau DA, Rajkumar SV, Kumar SK, Leukemia, 5/1/2012
• Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy  
  Sinha S, Lacy M, Mikhael J, Hayman S, Buadi F, Detweiler-Short K, Dispenzieri A, Gertz M , Dingli D, Rajkumar SV, Kumar SK, Leukemia, 4/1/2012
• Immunoglobulin light-chain amyloidosis: Growing recognition, new approaches to therapy, active clinical trials  
  Gertz MA, Dispenzieri A, Oncology, 1/1/2012
• Immunoglobulin light chain amyloidosis: 2012 update on diagnosis, prognosis, and treatment  
  Gertz MA, Am J Hematol, 1/1/2012
• Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma  
  Kapoor P, Kumar S, Mandrekar SJ, Laumann KM, Dispenzieri A, Lacy MQ, Dingli D, Gertz MA , Kyle RA, Greipp PR, Rajkumar SV, Witzig TE, Leukemia, 7/1/2011
• Join now to see all

Books/Book Chapters

• Multiple myeloma: diagnosis and treatment 
  Gertz MA , Rajkumar SVSpringer, New York2014
• Amyloidosis: diagnosis and treatment 
  Gertz MA , Rajkumar SVHumana Press, New York2010
• Hematologic malignancies: multiple myeloma and related plasma cell disorders 
  Gertz MA , Greipp PRSpringer, Berlin2004
• Amyloid and amyloidosis 1998 
  Kyle RA, Gertz MAEditors: Kyle RA, Gertz MA.The Parthenon Publishing Group, New York1999
• Join now to see all

Abstracts/Posters

• Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Use of Maintenance Therapy Post Autologous Stem Cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Optimal Therapy for Relapsed AL Amyloidosis Post Autologous Stem Cell Transplant
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
  Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• De novo multiple myeloma after kidney transplantation
  Safadi S, Leung N, Cosio F, Amer H, Gertz M , Rajkumar V, Hayman S, Lacy M, Dispenzieri A, Am J Kidney Dis, 5/1/2014
• Prediction of poor mobilization of autologous cd34+cells in multiple myeloma (mm): implications for risk-stratification
  Costa LJ, Nista EJ, Buadi FK, Lacy MQ, Dispenzieri A, Kramer CP, Kang Y, Gertz MA , Stuart RK, Kumar SK, Transfusion, 9/1/2013
• Electrocardiographic findings in transthyretin-related cardiac amyloidosis
  O'Donnell E, Klarich K, Olson A, Lin G, Brady P, Dispenzieri A, Gertz M , Zeldenrust S, Grogan M, J Am Coll Cardiol, 3/1/2013
• The natural history of cold agglutinin disease
  Swiecicki PL, Hegerova L, Gertz MA, Blood, 11/1/2012
• Treatment of advanced heart failure in cardiac amyloidosis with left ventricular assist device therapy
  Swiecicki PL, Edwards B, Kushwaha S, Dispenzieri A, Park S, Gertz MA, J Heart Lung Transplant, 4/1/2012
• Relapse of poems following autologous stem cell transplantation: a single center experience
  D'Souza A, Buadi FK, Lacy MQ, Gertz MA , Hayman SR, Kumar S, Dingli D, Zeldenrust SR, Dispenzieri A, Blood, 11/1/2011
• Long term outcome of renal failure in multiple myeloma following autologous stem cell transplant
  Glavey SV, Gertz MA , Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Dingli D, Hogan WJ, Gastineau DA, Leung N, Am J Kidney Dis, 4/1/2011
• Join now to see all

Lectures

• Adult Clinical Malignant Hematology 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Trainee Didactic Sessions: How to Set Up a Clinical Research Program 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Trainee Didactic Sessions: Bridging the Gap: How to Find Clinicians (PhD Topic) 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Trainee Didactic Sessions: Mentoring and Being Mentored 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Trainee Didactic Sessions: Basic Statistics for Hematologists 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long-Term Survivorship with Active Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Transplant for IgM amyloidosis 
  London, England - 8/1/2014
• Therapy is not indicated for high risk smoldering Waldenstrom Macroglobulinemia Debate 
  London, England - 8/1/2014
• Complications of IgM proteins 
  London, England - 8/1/2014
• Management Strategies for relapsed myeloma 
  Chicago, IL - 6/1/2014
• Amyloidosis 
  New York City, NY - 5/1/2014
• Mayo Clinic Young Investigators Forum 
  Chicago, IL - 4/1/2014
• Interesting patients of monoclonal gammopathy disorders 
  Herzlia, Israel - 4/1/2014
• Monoclonal Gammopathies in the Kidney 
  Herzlia, Israel - 4/1/2014
• Initial therapy for patients with myeloma based on Mayo Clinic criteria 
  Fukuoka, Japan - 4/1/2014
• Initial Therapy for multiple myeloma 
  Tokyo, Japan - 4/1/2014
• Measuring minimal residual disease in multiple myeloma 
  Abu Dhabi, United Arab Emirates - 3/1/2014
• Amyloidosis: Diagnosis & Treatment 
  Los Angeles, CA - 2/1/2014
• Therapy of Amyloidosis 
  Dallas, TX - 11/1/2013
• Join now to see all